Inpharma Weekly

, Volume 1550, Issue 1, pp 6–6 | Cite as

EMZ 702 + peginterferon-α-2a/ribavirin effective for refractory hepatitis C

Media release
  • 3 Downloads

Keywords

Adverse Event Clinical Trial Hepatitis Chronic Hepatitis Medium Release 

Copyright information

© Adis International Ltd 2006

Personalised recommendations